搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
FiercePharma
12 小时
Calcium+Company enriches comms work with new commercial planning, market access division
New York-based health comms agency Calcium+Company is living up to its name, strengthening the bones of its business with the ...
FiercePharma
8 小时
After FDA setbacks, Lexicon slashes commercial operations in transition back to clinical ...
For many biopharmas, it takes years of hard work to transition from being a clinical-stage drugmaker to a commercial one.
FiercePharma
9 小时
UK talc claimants set to file suit in class action vs. J&J
While Johnson & Johnson hopes to soon resolve more than 60,000 talc lawsuits with an $8 billion bankruptcy settlement in the ...
FiercePharma
10 小时
As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai ...
For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...
FiercePharma
10 小时
Meet 2024’s fiercest women in life sciences
Every year, Fierce’s pharma, biotech, and medtech teams come together to spotlight some of the fiercest women in life s | ...
FiercePharma
13 小时
Roche's Vabysmo shows potential to treat eye disorder common in Asia
Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of ...
FiercePharma
17 小时
Fierce Pharma Asia—Big Pharma’s China layoffs, CSL's site closure and Kyowa Kirin's ...
Australia’s CSL is winding down operations at a cell and gene therapy R&D site in California. Kyowa Kirin inked a commercialization and development deal with Kuro Oncology. Plus more.
FiercePharma
1 天
Biopharma status quo 'likely to persist' under Trump 2.0, though changes to IRA, FTC and ...
As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the ...
FiercePharma
1 天
Novartis, after slimming down, boosts growth projection through the end of the decade
As he introduced Novartis’ meet-the-management event Thursday in London, CEO Vas Narasimhan hammered home Novartis’ status as ...
FiercePharma
2 天
AstraZeneca to go on defense for Andexxa as FDA questions bleeding reversal agent's safety ...
As a council of outside experts prepares to meet Thursday to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety ...
FiercePharma
1 天
Trump leans toward selecting surgeon and COVID mandate critic Martin Makary for top FDA job ...
While president-elect Donald Trump has already made his leadership picks for the Department of Health and Human Services (HHS ...
FiercePharma
1 天
Jazz's HER2 bispecific snags FDA nod, teeing up showdown with AZ and Daiichi's Enhertu
The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈